Mankind Pharma Limited (BOM:543904)
India flag India · Delayed Price · Currency is INR
2,483.60
-17.00 (-0.68%)
At close: Oct 28, 2026

Mankind Pharma Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
11,3713,9174,0743,8203,0483,025
Short-Term Investments
15,2312,7873,9807,4641,4131,023
Trading Asset Securities
-15,37316,90822,58110,7558,745
Cash & Short-Term Investments
26,60222,07724,96233,86515,21612,793
Cash Growth
-23.96%-11.56%-26.29%122.56%18.94%-36.18%
Accounts Receivable
21,79317,29515,3838,4835,7643,882
Other Receivables
-492.3363437.1321.02347.23
Receivables
21,82017,83115,7868,9496,1024,241
Inventory
23,45121,44520,93715,53514,98517,602
Prepaid Expenses
-515611.2603.9331.61,360
Other Current Assets
7,6907,6757,5876,7306,6458,072
Total Current Assets
79,56369,54269,88365,68243,27944,068
Property, Plant & Equipment
37,89036,14332,14031,38730,17023,896
Long-Term Investments
5,3034,5174,8483,1113,5782,404
Goodwill
64,87264,92664,926200.2200.23204.42
Other Intangible Assets
93,29696,411101,23616,63017,58418,742
Long-Term Deferred Tax Assets
2,8933,2471,079803.9297.77392.86
Other Long-Term Assets
5,7276,0093,4841,8182,0461,770
Total Assets
289,544280,795277,595119,63397,15491,477

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
16,31013,41311,3347,77110,08210,764
Accrued Expenses
-8,5217,8125,4871,7102,598
Short-Term Debt
-8,21526,9571,5151,1508,052
Current Portion of Long-Term Debt
22,77425,6162,611196.9244.68242.47
Current Portion of Leases
430.1357.7143.934.225.5720.57
Current Income Taxes Payable
939.6109.1180.883.8462.56150.9
Current Unearned Revenue
-1,9221,9401,8591,6621,394
Other Current Liabilities
18,3946,9195,6564,2513,2943,013
Total Current Liabilities
58,84865,07356,63621,19718,63126,235
Long-Term Debt
30,02728,21255,262248.7231.47491.94
Long-Term Leases
985.7714.3140.377.151.7829.9
Long-Term Unearned Revenue
299.2299.4200229.6254.95201.54
Pension & Post-Retirement Benefits
2,6442,4871,5511,231978.89800.04
Long-Term Deferred Tax Liabilities
18,18718,40018,125890.7773.12556.21
Total Liabilities
110,991115,185131,91423,87520,92228,314

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
413412.8412.6400.6400.59400.59
Additional Paid-In Capital
-30,43230,075421.2421.17421.17
Retained Earnings
-140,420121,451101,56682,49969,729
Comprehensive Income & Other
175,409-8,261-8,615-8,757-8,969-8,999
Total Common Equity
175,822163,003143,32493,63174,35261,552
Minority Interest
2,7302,6072,3582,1271,8811,611
Shareholders' Equity
178,552165,611145,68295,75876,23363,163
Total Liabilities & Equity
289,544280,795277,595119,63397,15491,477

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
54,21763,11585,1152,0721,7048,836
Net Cash (Debt)
-27,615-41,039-60,15331,79313,5123,957
Net Cash Growth
---135.29%241.51%-77.06%
Net Cash Per Share
-66.79-99.29-148.6379.2533.739.88
Filing Date Shares Outstanding
412.93412.83412.58400.64400.59400.59
Total Common Shares Outstanding
412.93412.83412.58400.59400.59400.59
Working Capital
20,7154,47013,24744,48524,64717,834
Book Value Per Share
425.79394.85347.39233.73185.61153.65
Tangible Book Value
17,6551,666-22,83876,80056,56842,606
Tangible Book Value Per Share
42.754.04-55.35191.72141.21106.36
Land
-3,8083,8013,5303,5282,435
Buildings
-10,62610,37312,48710,4605,863
Machinery
-26,29624,51321,50417,35213,921
Construction In Progress
-6,5483,0612,0714,9326,699
Leasehold Improvements
-136.7101.988.888.7464.47